Report Code: A13436 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Prevalence of cancer has witnessed two-fold growth around the globe in recent years, owing to poor lifestyle, increased stress burdens, smocking & alcohol, and use of contraceptives in few cases. It is the second leading cause of global deaths, including lung cancer as the most potent one. Major symptoms of premature cancer include skin lump, changes in bowel, fatigue, and persistent cough. This enlightens the underlying need of design and development of new age effective therapies for cancer treatment. Under treatment procedure, primary treatment, adjuvant treatment, and palliative treatment form different arrays. Among primary treatment scenarios, surgeries and chemotherapies are the most effective techniques. Goal under surgery procedure is to completely remove cancer from the body.
Lately, platinum compounds have been at the fulcrum of cancer treatment especially ovarian cancer, bladder cancer, and testes cancer. The compounds have been known to crosslink with purine bases of the DNA, interfering with DNA mechanisms, causing DNA damage and gradually inducing apoptosis in the cancerous cells. Cisplatin is the most frequently used platinum drug for cancer treatment. It is a deep white or yellow or deep yellow in powder form at the room temperature. Cisplatin is shown to have cytotoxic properties, and is also used in combination with other cancer drugs as part of combination therapeutic strategy for various human cancers. Carboplatin, a derivative of cisplatin, is used to treat ovarian and lung cancer.
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the platinum based drugs market.
Top Impacting Factors
Platinum based Drugs Market Trends
Key Benefits of the Report
Questions Answered in the Platinum-based Drugs Report
Platinum-based Drugs Market Report Highlights
Aspects | Details |
---|---|
By Drug Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Lab, Novartis AG, Accord Healthcare, SK Chemicals, Qilu Pharmaceuticals Ltd., Debiopharm Group, Ask-Pharma, Sun Pharma, Pfizer Inc |
Loading Table Of Content...
Start reading.
This Report and over 71,223+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers